Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Novo Nordisk A/S
Javed Butler; Sanjiv J Shah; Mark C Petrie; Barry A Borlaug; Steen Z Abildstrøm; Melanie J Davies; G Kees Hovingh; Dalane W Kitzman; Daniél Vega Møller; Subodh Verma; Mette Nygaard Einfeldt; Marie L Lindegaard; Søren Rasmussen; Walter Abhayaratna; Fozia Z Ahmed; Tuvia Ben-Gal; Vijay Chopra; Justin A Ezekowitz; Michael Fu; Hiroshi Ito; Małgorzata Lelonek; Vojtěch Melenovský; Bela Merkely; Julio Núñez; Eduardo Perna; Morten Schou; Michele Senni; Kavita Sharma; Peter van der Meer; Dirk Von Lewinski; Dennis Wolf; Mikhail N Kosiborod; STEP-HFpEF Trial Committees and Investigators